Alessio Fabozzi

SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer

Carminia Maria Della Corte, Claudio Bellevicine, Giovanni Vicidomini et al. · Clinical Cancer Research · 2015 · 119 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

Guido Giordano, Antonio Febbraro, Eugenio Tomaselli et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 87 citations · Full text

Medicine, Immunology, Oncology +17

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro et al. · BMC Cancer · 2016 · 58 citations · Full text

Medicine, Oncology, Pharmacology +13

The immune cell landscape of metastatic uveal melanoma correlates with overall survival

Anna Tosi, Rocco Cappellesso, Angelo Paolo Dei Tos et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 44 citations · Full text

Medicine, Immunology, Oncology +17

<i>BRAF</i> Gene Copy Number and Mutant Allele Frequency Correlate with Time to Progression in Metastatic Melanoma Patients Treated with MAPK Inhibitors

Camilla Stagni, Carolina Zamuner, Lisa Elefanti et al. · Molecular Cancer Therapeutics · 2018 · 35 citations · Full text

Medicine, Genetics, Oncology +17